Study of 621 people in the UK with mild COVID-19 infections found that people who received two vaccine doses could still pass the infection on to vaccinated and unvaccinated household members. The analysis found that 25% of vaccinated household contacts tested positive for COVID-19 compared with 38% of unvaccinated household contacts. The infectiousness of vaccinated…
Uganda on 13 November received 1,904,140 doses of the Moderna COVID-19 vaccine, donated by the Canadian Government and shipped via the COVAX facility, —the world’s facility for universal access to COVID-19 vaccines. The arrival marks an important step towards the goal to ensure equitable distribution of COVID-19 vaccines globally. Uganda is targeting the vaccination of…
By World Health Organisation Africa is expected to experience the highest increase in diabetes globally. The number of people suffering from the disease is predicted to rise to 55 million by 2045—a 134% spike compared with 2021. At 70%, the continent also has the world’s highest number of people who do not know they have…
Africa’s sharp increase in diabetes is clashing with the COVID-19 pandemic and poor access to vaccines says the World Health Organsiation. Africa’s death rates from COVID-19 infections are significantly higher in patients with diabetes, according to a preliminary analysis which the World Health Organization (WHO) presented in advance of the World Diabetes Day on 14…
BY WHO Uganda Team Uganda launched the Third Edition of the National Guidelines for Integrated Diseases Surveillance and Response (IDSR) at Golden Tulip Hotel in Kampala. The third edition highlights new methods of disease detection, reporting, and provision of real-time surveillance data using new technologies and platforms. The platforms include event-based disease surveillance, community-based surveillance,…
Cote d’Ivoire has launched Ebola vaccination of high-risk populations, including health workers and first responders in Abidjan, where an Ebola outbreak was declared on 14 August. The country was able to swiftly begin the vaccination on 16 August with the rVSV-ZEBOV Ebola vaccine manufactured by Merck as the vaccine doses that the World Health Organization…
26 January 2021 – Important advances in HIV prevention research were announced today at the 4th HIV Research for Prevention Conference (HIVR4P // Virtual), convened by IAS – the International AIDS Society. Highlights included findings from a pair of trials evaluating whether infusions with a broadly neutralizing antibody (bNAb) can prevent HIV acquisition and positive…
SEATTLE – January 27, 2021 – Today, Bill and Melinda Gates share their 2021 Annual Letter, “The Year Global Health Went Local.” In this year’s letter, Bill and Melinda reflect on the worldwide impact of COVID-19 and the global collaboration and scientific innovation fueling one of the largest public health efforts in history. They share…
Thirteen African countries and an international network of research institutions have joined forces to launch the largest COVID-19 clinical trial in mild-to-moderate outpatients in Africa. The ANTICOV clinical trial aims to respond to the urgent need to identify treatments that can be used to treat mild and moderate cases of COVID-19 early and prevent spikes…
Regulatory review and introduction plans must be accelerated New York City, November 9, 2020— AVAC enthusiastically welcomes the news that another trial of the long-acting, injectable antiretroviral cabotegravir (CAB-LA) for HIV prevention for HIV pre-exposure prophylaxis (PrEP) has demonstrated safety and efficacy, this time among cisgender women. Today’s announcement from ViiV, the US National Institute of Allergy and…